- Report
- February 2024
- 175 Pages
Global
From €4972EUR$5,000USD£4,126GBP
- Report
- December 2024
- 164 Pages
Global
From €5419EUR$5,450USD£4,498GBP
- Report
- July 2024
- 142 Pages
Global
From €2982EUR$2,999USD£2,475GBP
- Report
- January 2024
- 200 Pages
Global
From €4127EUR$4,150USD£3,425GBP
- Report
- July 2024
- 164 Pages
Global
From €2486EUR$2,500USD£2,063GBP
- Report
- July 2024
- 121 Pages
North America
From €2982EUR$2,999USD£2,475GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1591EUR$1,600USD£1,320GBP
€1989EUR$2,000USD£1,651GBP
- Report
- July 2024
- 162 Pages
Africa
From €2486EUR$2,500USD£2,063GBP
- Report
- July 2024
- 288 Pages
Global
From €5425EUR$5,646USD£4,350GBP
- Report
- October 2024
- 192 Pages
Global
From €3525EUR$3,545USD£2,926GBP
€3917EUR$3,939USD£3,251GBP
- Report
- October 2024
- 190 Pages
Global
From €3525EUR$3,545USD£2,926GBP
€3917EUR$3,939USD£3,251GBP
- Report
- October 2024
- 192 Pages
Global
From €3525EUR$3,545USD£2,926GBP
€3917EUR$3,939USD£3,251GBP
- Report
- October 2024
- 192 Pages
Global
From €3525EUR$3,545USD£2,926GBP
€3917EUR$3,939USD£3,251GBP
- Report
- October 2024
- 195 Pages
Global
From €3525EUR$3,545USD£2,926GBP
€3917EUR$3,939USD£3,251GBP
- Report
- November 2024
- 120 Pages
Global
From €5917EUR$5,950USD£4,910GBP
- Report
- October 2024
- 198 Pages
Global
From €3525EUR$3,545USD£2,926GBP
€3917EUR$3,939USD£3,251GBP
- Report
- May 2024
- 134 Pages
Global
From €6462EUR$6,499USD£5,364GBP
- Report
- March 2024
- 118 Pages
Global
From €4475EUR$4,500USD£3,714GBP
- Report
- June 2024
- 200 Pages
Global
From €6324EUR$6,360USD£5,249GBP
€7905EUR$7,950USD£6,561GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1591EUR$1,600USD£1,320GBP
€1989EUR$2,000USD£1,651GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more